Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-27

Clinical Trial Update: Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap [NA]

View source ↗

Summary

Completed clinical trial evaluating the effectiveness of the ClearGuard HD End Cap for patients with end-stage renal disease; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ClearGuard HD End Cap

Snippet

Sponsor: Pursuit Vascular, Inc. | Conditions: End Stage Renal Disease (ESRD) | NA | Status: COMPLETED | Results posted: 2019-02-27